Aprea Therapeutics
APRE
#11121
Rank
HK$25.47 M
Marketcap
HK$1.80
Share price
-53.56%
Change (1 day)
-80.28%
Change (1 year)

EPS for Aprea Therapeutics (APRE)

EPS in 2026 (TTM): -HK$8.42

According to Aprea Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$8.47. In 2025 the company made an earnings per share (EPS) of -HK$15.52 an increase over its 2024 EPS that were of -HK$18.66.

EPS history for Aprea Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$8.42-45.75%
2025-HK$15.52-16.81%
2024-HK$18.66
2022-HK$762.02177.74%
2021-HK$274.36-31.1%
2020-HK$398.2270.91%
2019-HK$233.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amedisys
AMED
HK$20.46-341.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
HK$11.84-239.81%๐Ÿ‡บ๐Ÿ‡ธ USA